FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

Xiaoyong Fu, Rinath Jeselsohn, Resel Pereira, Emporia F. Hollingsworth, Chad J. Creighton, Fugen Li, Martin Shea, Agostina Nardone, Carmine De Angelis, Laura Heiser, Pavana Anur, Nicholas Wang, Catherine S. Grasso, Paul Spellman, Obi L. Griffith, Anna Tsimelzon, Carolina Gutierrez, Shixia Huang, Dean P. Edwards, Meghana V. Trivedi & 7 others Mothaffar F. Rimawi, Dolores Lopez-Terrada, Susan G. Hilsenbeck, Joe Gray, Myles Brown, C. Kent Osborne, Rachel Schiff

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Forkhead box protein A1 (FOXA1) is a pioneer factor of estrogen receptor α (ER)-chromatin binding and function, yet its aberration in endocrine-resistant (Endo-R) breast cancer is unknown. Here, we report preclinical evidence for a role of FOXA1 in Endo-R breast cancer as well as evidence for its clinical significance. FOXA1 is gene-amplified and/or overexpressed in Endo-R derivatives of several breast cancer cell line models. Induced FOXA1 triggers oncogenic gene signatures and proteomic profiles highly associated with endocrine resistance. Integrated omics data reveal IL8 as one of the most perturbed genes regulated by FOXA1 and ER transcriptional reprogramming in Endo-R cells. IL-8 knockdown inhibits tamoxifen-resistant cell growth and invasion and partially attenuates the effect of overexpressed FOXA1. Our study highlights a role of FOXA1 via IL-8 signaling as a potential therapeutic target in FOXA1-overexpressing ER-positive tumors.

Original languageEnglish (US)
Pages (from-to)E6600-E6609
JournalProceedings of the National Academy of Sciences of the United States of America
Volume113
Issue number43
DOIs
StatePublished - Oct 25 2016

Fingerprint

Interleukin-8
Transcriptome
Estrogen Receptors
Breast Neoplasms
Hepatocyte Nuclear Factor 3-alpha
Genes
Endocrine Cells
Tamoxifen
Proteomics
Chromatin
Cell Line
Growth
Neoplasms
Therapeutics

Keywords

  • Breast cancer
  • Endocrine resistance
  • Estrogen receptor
  • FOXA1
  • Transcriptional reprogramming

ASJC Scopus subject areas

  • General

Cite this

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer. / Fu, Xiaoyong; Jeselsohn, Rinath; Pereira, Resel; Hollingsworth, Emporia F.; Creighton, Chad J.; Li, Fugen; Shea, Martin; Nardone, Agostina; De Angelis, Carmine; Heiser, Laura; Anur, Pavana; Wang, Nicholas; Grasso, Catherine S.; Spellman, Paul; Griffith, Obi L.; Tsimelzon, Anna; Gutierrez, Carolina; Huang, Shixia; Edwards, Dean P.; Trivedi, Meghana V.; Rimawi, Mothaffar F.; Lopez-Terrada, Dolores; Hilsenbeck, Susan G.; Gray, Joe; Brown, Myles; Osborne, C. Kent; Schiff, Rachel.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, No. 43, 25.10.2016, p. E6600-E6609.

Research output: Contribution to journalArticle

Fu, X, Jeselsohn, R, Pereira, R, Hollingsworth, EF, Creighton, CJ, Li, F, Shea, M, Nardone, A, De Angelis, C, Heiser, L, Anur, P, Wang, N, Grasso, CS, Spellman, P, Griffith, OL, Tsimelzon, A, Gutierrez, C, Huang, S, Edwards, DP, Trivedi, MV, Rimawi, MF, Lopez-Terrada, D, Hilsenbeck, SG, Gray, J, Brown, M, Osborne, CK & Schiff, R 2016, 'FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer', Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 43, pp. E6600-E6609. https://doi.org/10.1073/pnas.1612835113
Fu, Xiaoyong ; Jeselsohn, Rinath ; Pereira, Resel ; Hollingsworth, Emporia F. ; Creighton, Chad J. ; Li, Fugen ; Shea, Martin ; Nardone, Agostina ; De Angelis, Carmine ; Heiser, Laura ; Anur, Pavana ; Wang, Nicholas ; Grasso, Catherine S. ; Spellman, Paul ; Griffith, Obi L. ; Tsimelzon, Anna ; Gutierrez, Carolina ; Huang, Shixia ; Edwards, Dean P. ; Trivedi, Meghana V. ; Rimawi, Mothaffar F. ; Lopez-Terrada, Dolores ; Hilsenbeck, Susan G. ; Gray, Joe ; Brown, Myles ; Osborne, C. Kent ; Schiff, Rachel. / FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer. In: Proceedings of the National Academy of Sciences of the United States of America. 2016 ; Vol. 113, No. 43. pp. E6600-E6609.
@article{39c58618140d40c491f3dde10d17fd8c,
title = "FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer",
abstract = "Forkhead box protein A1 (FOXA1) is a pioneer factor of estrogen receptor α (ER)-chromatin binding and function, yet its aberration in endocrine-resistant (Endo-R) breast cancer is unknown. Here, we report preclinical evidence for a role of FOXA1 in Endo-R breast cancer as well as evidence for its clinical significance. FOXA1 is gene-amplified and/or overexpressed in Endo-R derivatives of several breast cancer cell line models. Induced FOXA1 triggers oncogenic gene signatures and proteomic profiles highly associated with endocrine resistance. Integrated omics data reveal IL8 as one of the most perturbed genes regulated by FOXA1 and ER transcriptional reprogramming in Endo-R cells. IL-8 knockdown inhibits tamoxifen-resistant cell growth and invasion and partially attenuates the effect of overexpressed FOXA1. Our study highlights a role of FOXA1 via IL-8 signaling as a potential therapeutic target in FOXA1-overexpressing ER-positive tumors.",
keywords = "Breast cancer, Endocrine resistance, Estrogen receptor, FOXA1, Transcriptional reprogramming",
author = "Xiaoyong Fu and Rinath Jeselsohn and Resel Pereira and Hollingsworth, {Emporia F.} and Creighton, {Chad J.} and Fugen Li and Martin Shea and Agostina Nardone and {De Angelis}, Carmine and Laura Heiser and Pavana Anur and Nicholas Wang and Grasso, {Catherine S.} and Paul Spellman and Griffith, {Obi L.} and Anna Tsimelzon and Carolina Gutierrez and Shixia Huang and Edwards, {Dean P.} and Trivedi, {Meghana V.} and Rimawi, {Mothaffar F.} and Dolores Lopez-Terrada and Hilsenbeck, {Susan G.} and Joe Gray and Myles Brown and Osborne, {C. Kent} and Rachel Schiff",
year = "2016",
month = "10",
day = "25",
doi = "10.1073/pnas.1612835113",
language = "English (US)",
volume = "113",
pages = "E6600--E6609",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "43",

}

TY - JOUR

T1 - FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

AU - Fu, Xiaoyong

AU - Jeselsohn, Rinath

AU - Pereira, Resel

AU - Hollingsworth, Emporia F.

AU - Creighton, Chad J.

AU - Li, Fugen

AU - Shea, Martin

AU - Nardone, Agostina

AU - De Angelis, Carmine

AU - Heiser, Laura

AU - Anur, Pavana

AU - Wang, Nicholas

AU - Grasso, Catherine S.

AU - Spellman, Paul

AU - Griffith, Obi L.

AU - Tsimelzon, Anna

AU - Gutierrez, Carolina

AU - Huang, Shixia

AU - Edwards, Dean P.

AU - Trivedi, Meghana V.

AU - Rimawi, Mothaffar F.

AU - Lopez-Terrada, Dolores

AU - Hilsenbeck, Susan G.

AU - Gray, Joe

AU - Brown, Myles

AU - Osborne, C. Kent

AU - Schiff, Rachel

PY - 2016/10/25

Y1 - 2016/10/25

N2 - Forkhead box protein A1 (FOXA1) is a pioneer factor of estrogen receptor α (ER)-chromatin binding and function, yet its aberration in endocrine-resistant (Endo-R) breast cancer is unknown. Here, we report preclinical evidence for a role of FOXA1 in Endo-R breast cancer as well as evidence for its clinical significance. FOXA1 is gene-amplified and/or overexpressed in Endo-R derivatives of several breast cancer cell line models. Induced FOXA1 triggers oncogenic gene signatures and proteomic profiles highly associated with endocrine resistance. Integrated omics data reveal IL8 as one of the most perturbed genes regulated by FOXA1 and ER transcriptional reprogramming in Endo-R cells. IL-8 knockdown inhibits tamoxifen-resistant cell growth and invasion and partially attenuates the effect of overexpressed FOXA1. Our study highlights a role of FOXA1 via IL-8 signaling as a potential therapeutic target in FOXA1-overexpressing ER-positive tumors.

AB - Forkhead box protein A1 (FOXA1) is a pioneer factor of estrogen receptor α (ER)-chromatin binding and function, yet its aberration in endocrine-resistant (Endo-R) breast cancer is unknown. Here, we report preclinical evidence for a role of FOXA1 in Endo-R breast cancer as well as evidence for its clinical significance. FOXA1 is gene-amplified and/or overexpressed in Endo-R derivatives of several breast cancer cell line models. Induced FOXA1 triggers oncogenic gene signatures and proteomic profiles highly associated with endocrine resistance. Integrated omics data reveal IL8 as one of the most perturbed genes regulated by FOXA1 and ER transcriptional reprogramming in Endo-R cells. IL-8 knockdown inhibits tamoxifen-resistant cell growth and invasion and partially attenuates the effect of overexpressed FOXA1. Our study highlights a role of FOXA1 via IL-8 signaling as a potential therapeutic target in FOXA1-overexpressing ER-positive tumors.

KW - Breast cancer

KW - Endocrine resistance

KW - Estrogen receptor

KW - FOXA1

KW - Transcriptional reprogramming

UR - http://www.scopus.com/inward/record.url?scp=84992371656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992371656&partnerID=8YFLogxK

U2 - 10.1073/pnas.1612835113

DO - 10.1073/pnas.1612835113

M3 - Article

VL - 113

SP - E6600-E6609

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 43

ER -